-
Vitamin K1 Induced Cytotoxic Effects and Transcriptomic Analysis in Jurkat T Lymphocyte Leukemia Cells
16 Dec 2025 20:19 GMT
… -treatment with VK1 and Sorafenib induces growth inhibition and … malignant thymomas: final report. Lung Cancer. 2004;44(3):369–379 … QJ. Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis … of vitamin K2 therapy for lung cancer. Int J Oncol. …
-
Dihydroartemisinin: A Promising Therapeutic Agent Against the Hepatitis-to-Hepatocellular Carcinoma Cascade
15 Dec 2025 10:47 GMT
… its efficacy compared to sorafenib monotherapy. Treatment-related … lipid metabolism. In lung cancer cells, DHA enhances … of combined dihydroartemisinin and sorafenib. Biomed. Pharmacother. 2020 … and DNA damage for lung cancer immunotherapy. Phytomedicine. 2023 …
-
Pyrazoline B Induces Oxidative Stress Mediated Toxicity, Cell Cycle Arrest, and Caspase-Independent Apoptosis in BT-474 Human Breast Cancer Cells
13 Dec 2025 10:08 GMT
… sunitinib, erlotinib, and sorafenib.65,73
Inducing cancer cell … agents against paclitaxel-and sorafenib-resistant papillary thyroid carcinoma. … endothelial growth factor in lung cancer. Oncol Lett. 2016; … of non-small-cell lung cancer cells by targeting EGFR…
-
Camrelizumab Combo Doubles 5-Year Survival in Phase 3 Lung Cancer Trial
02 Apr 2025 23:47 GMT
… patients with advanced squamous lung cancer, according to a press … at the 2025 European Lung Cancer Congress (ELCC). The trial … Center consistently shows that lung cancer has the highest incidence … 15.2 months with sorafenib. Median progression-free survival …
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Perioperative Regimen of Neoadjuvant Opdivo® (nivolumab) and Chemotherapy Followed by Surgery and Adjuvant Opdivo for Resectable Non-Small Cell Lung Cancer in Patients with Tumor Cell PD-L1...
28 Mar 2025 13:11 GMT
… of four tumor types: lung cancer, bladder cancer, esophageal … pathologic response.
About Lung Cancer
Lung cancer is the leading cause … been previously treated with sorafenib. This indication is … lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity
17 Jul 2025 18:58 GMT
… without any further purification. Sorafenib (Ark Pharma Scientific, … -mediated ASGPR targeting. Sorafenib, released from hepatocytes, … Phosphate buffer solution; Sor, Sorafenib; STING, Stimulator of … gefitinib resistance in lung cancer by activating ERBB3 …
-
Bristol Myers Squibb Announces Opdivo® Plus Chemotherapy as the First and Only Neoadjuvant-Only Immuno-Oncology Therapy to Demonstrate Statistically Significant and Clinically Meaningful Overall Survival in Resectable Non-Small Cell Lung Cancer
19 Feb 2025 12:09 GMT
… positive) non-small cell lung cancer (NSCLC).
OPDIVO® (nivolumab … been previously treated with sorafenib. This indication is … metastatic non-small cell lung cancer, in combination with … cell lung cancer; Checkmate 816–neoadjuvant non-small cell lung cancer, …
-
A Comprehensive Review of Advances in Molecular Mechanisms and Targeted Therapies for the Specific Type of Cystic Lung Cancer
11 Feb 2025 15:06 GMT
… is the most neuroendocrine lung tumor, and it also … Lung cancers associated with cystic airspaces: CT features and pathologic correlation. Lung Cancer … Raez LE. Efficacy of sorafenib, a multi-tyrosine kinase … -L1 expression in rare lung tumors. Pathol Oncol Res. …
-
Tyrosine Kinase Inhibitors Market is Forecasted to Reach a Value of US $87.14 Billion by 2029
09 Dec 2025 10:30 GMT
… Application: Chronic Myeloid Leukemia (CML), Lung Cancer, Breast Cancer, Renal Cell Cancer … Receptor (VEGFR) Tyrosine Kinase Inhibitors: Sorafenib, Sunitinib, Pazopanib, Axitinib, Regorafenib
4 …
-
Anlotinib or Bevacizumab Combined with Taxane/Capecitabine for the Second-Line or Subsequent Treatment of HER-2 Negative Metastatic Breast Cancer: A Retrospective Cohort Study
08 Dec 2025 08:27 GMT
… , and non-small cell lung cancer. It improves objective response rate … and non-small cell lung cancers,14 and has NMPA approval … Hermann RC, et al. Sorafenib or placebo with either gemcitabine … for extensive-stage small cell lung cancer (SCLC): the final …
About
© 1995-2025